← All companies
Stayble Therapeutics
Stayble is a clinical stage pharmaceutical company developing STA363, a treatment for disc-related chronic low back pain
📍 Gothenburg
Stats
- Employees (LinkedIn)
- 9
- Size bucket
- 2-10 employees
- Followers
- 871
- Founded
- 2015
- Org type
- Partnership
- Country
- SE
- LinkedIn ID
- 9388643
- Slug
- stayble-therapeutics
Industries
Pharmaceutical Manufacturing
Specialties
Pharmaceutical development and Chronic low back pain
About
Stayble is a clinical stage pharmaceutical company developing the injectable treatment STA363 for disc hernia. The treatment is aimed at patients whose back pain persists after physiotherapy and painkillers. The injection is given once, and the effect is expected to remain throughout the entirety of the patient’s life and to require minimal rehabilitation. The Company’s focus is set upon the continued clinical development of the ongoing clinical phase 1b study. Stayble’s vision is to develop STA363 as a new standard treatment for patients suffering from pain caused by disc hernia.
Locations (1)
- Medicinaregatan 8A, Gothenburg, 41390, SE